OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Clinical and Translational Neurology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis	115
Genetic Profile and Symptom Pattern Explain Variability of Deep Brain Stimulation Effect in Dystonia	91
The case of a 49‐year‐old man with involuntary toe movements	77
Issue Information	73
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	63
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	60
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	57
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	57
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	55
Cognitive impairment in pulmonary arterial hypertension	55
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	44
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	43
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	42
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	41
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	38
Discrepant expressive language lateralization in children and adolescents with epilepsy	38
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	37
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	37
Order from chaos: Using CSF proteomics to predict ALS progression	37
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	37
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	36
Association of serum Spp1 levels with disease progression in ALS and SBMA	35
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	35
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	33
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	33

Issue Information	33
Peripheral nervous system manifestations of MOG antibody associated disease	33
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	33
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study	32
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers	31
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	31
Visceral and emotional responses to direct electrical stimulations of the cortex	31
Cerebellar impulsivity–compulsivity assessment scale	31